Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)

Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8) Publisher Pubmed

Shiraji ST ; Biglari M ; Barkhordar M ; Seghatoleslami G ; Janbabai G ; Babakhani D ; Yaghmaie M ; Rad S ; Vaezi M ; Alimoghadam K ; Fumani HK ; Mousavi SA ; Ghavamzadeh A

Source: Annals of Hematology Published:2026

Abstract

In the published version of this article, there were errors in the author byline. The first author’s name was incorrectly published and should be corrected to “Sahar Tavakkoli Shiraji”. In addition, the name “Maryam Barkhordar” was inadvertently duplicated; the second occurrence should be removed, with the correct listing retaining her position as the third author. The original article has been corrected. © The Author(s) 2026.

Related Docs

View other Related Docs

1. Corrigendum to “Pneumocystis Pneumonia in Covid-19 Patients: A Comprehensive Review” [Heliyon 9(2) (February 2023) E13618] (Heliyon (2023) 9(2), (S2405844023008253), (10.1016/J.Heliyon.2023.E13618)), Heliyon (2023)

2. Correction To: New Engineered Fusion Peptide With Dual Functionality: Antibacterial and Strong Binding to Hydroxyapatite (International Journal of Peptide Research and Therapeutics, (2020), 26, 3, (1629-1639), 10.1007/S10989-019-09963-8), International Journal of Peptide Research and Therapeutics (2020)

3. Corrigendum: Natural Killer Cells From Patients With Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of Cd56bright Nkg2a+++ Cells, and yet Display Increased Degranulation and Higher Perforin Content [Front Immunol, 8, (2017), (798)] Doi: 10.3389/Fimmu.2017.00798, Frontiers in Immunology (2017)

Experts (# of related papers)

View all Related Experts

Nasim Vousooghi (1)

Marjan Yaghmaie (1)

Style	Citing Format
MLA	Shiraji ST, et al.. "Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)." Annals of Hematology, vol. 105, no. 6, 2026, pp. -.
APA	Shiraji ST, Biglari M, Barkhordar M, Seghatoleslami G, Janbabai G, Babakhani D, Yaghmaie M, Rad S, Vaezi M, Alimoghadam K, Fumani HK, Mousavi SA, Ghavamzadeh A (2026). Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8). Annals of Hematology, 105(6), -.
Chicago	Shiraji ST, Biglari M, Barkhordar M, Seghatoleslami G, Janbabai G, Babakhani D, Yaghmaie M, et al.. "Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)." Annals of Hematology 105, no. 6 (2026): -.
Harvard	Shiraji ST et al. (2026) 'Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)', Annals of Hematology, 105(6), pp. -.
Vancouver	Shiraji ST, Biglari M, Barkhordar M, Seghatoleslami G, Janbabai G, Babakhani D, et al.. Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8). Annals of Hematology. 2026;105(6):-.
BibTex	@article{ author = {Shiraji ST and Biglari M and Barkhordar M and Seghatoleslami G and Janbabai G and Babakhani D and Yaghmaie M and Rad S and Vaezi M and Alimoghadam K and Fumani HK and Mousavi SA and Ghavamzadeh A}, title = {Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)}, journal = {Annals of Hematology}, volume = {105}, number = {6}, pages = {-}, year = {2026} }
RIS	TY - JOUR AU - Shiraji ST AU - Biglari M AU - Barkhordar M AU - Seghatoleslami G AU - Janbabai G AU - Babakhani D AU - Yaghmaie M AU - Rad S AU - Vaezi M AU - Alimoghadam K AU - Fumani HK AU - Mousavi SA AU - Ghavamzadeh A TI - Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8) JO - Annals of Hematology VL - 105 IS - 6 SP - EP - PY - 2026 ER -

Style

Citing Format

MLA

Shiraji ST, et al.. "Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)." Annals of Hematology, vol. 105, no. 6, 2026, pp. -.

APA

Shiraji ST, Biglari M, Barkhordar M, Seghatoleslami G, Janbabai G, Babakhani D, Yaghmaie M, Rad S, Vaezi M, Alimoghadam K, Fumani HK, Mousavi SA, Ghavamzadeh A (2026). Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8). Annals of Hematology, 105(6), -.

Chicago

Shiraji ST, Biglari M, Barkhordar M, Seghatoleslami G, Janbabai G, Babakhani D, Yaghmaie M, et al.. "Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)." Annals of Hematology 105, no. 6 (2026): -.

Harvard

Shiraji ST et al. (2026) 'Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)', Annals of Hematology, 105(6), pp. -.

Vancouver

Shiraji ST, Biglari M, Barkhordar M, Seghatoleslami G, Janbabai G, Babakhani D, et al.. Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8). Annals of Hematology. 2026;105(6):-.

BibTex

@article{ author = {Shiraji ST and Biglari M and Barkhordar M and Seghatoleslami G and Janbabai G and Babakhani D and Yaghmaie M and Rad S and Vaezi M and Alimoghadam K and Fumani HK and Mousavi SA and Ghavamzadeh A}, title = {Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)}, journal = {Annals of Hematology}, volume = {105}, number = {6}, pages = {-}, year = {2026} }

RIS

TY - JOUR
AU - Shiraji ST
AU - Biglari M
AU - Barkhordar M
AU - Seghatoleslami G
AU - Janbabai G
AU - Babakhani D
AU - Yaghmaie M
AU - Rad S
AU - Vaezi M
AU - Alimoghadam K
AU - Fumani HK
AU - Mousavi SA
AU - Ghavamzadeh A
TI - Correction To: Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort (Annals of Hematology, (2026), 105, 5, (273), 10.1007/S00277-026-07027-8)
JO - Annals of Hematology
VL - 105
IS - 6
SP -
EP -
PY - 2026
ER -

Science Communicator Platform

Authors

Abstract